Menopause
Welcome,         Profile    Billing    Logout  
 54 Companies   104 Products   104 Products   62 Mechanisms of Action   2 Trials   669 News 


12345678910111213»
  • ||||||||||  Phase classification:  Women's Isoflavone Soy Health (WISH) Trial (clinicaltrials.gov) -  May 6, 2023   
    P2,  N=350, Completed, 
    Completed --> Terminated; accrual rate lower than anticipated; funding expired Phase classification: P2/3 --> P2
  • ||||||||||  NN1213 / Novo Nordisk
    Enrollment closed, Trial completion date, Trial primary completion date:  Behavioral Treatment of Menopausal Insomnia; Sleep and Daytime Outcomes (clinicaltrials.gov) -  Oct 31, 2018   
    P=N/A,  N=150, Active, not recruiting, 
    Recruiting --> Completed Recruiting --> Active, not recruiting | Trial completion date: Jun 2018 --> Dec 2018 | Trial primary completion date: Jan 2018 --> Dec 2018
  • ||||||||||  progesterone / Generic mfg.
    Enrollment change, Trial termination:  Evaluating the Roles of Estrogen and Progesterone in Heart Metabolism (clinicaltrials.gov) -  Oct 16, 2018   
    P=N/A,  N=22, Terminated, 
    Recruiting --> Completed | N=150 --> 55 N=38 --> 22 | Completed --> Terminated; Atypically high dropout rate.
  • ||||||||||  letrozole / Generic mfg.
    Trial completion date, Trial termination, Trial primary completion date, Surgery:  Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery (clinicaltrials.gov) -  Oct 15, 2018   
    P1,  N=213, Terminated, 
    N=38 --> 22 | Completed --> Terminated; Atypically high dropout rate. Trial completion date: Sep 2019 --> Sep 2018 | Active, not recruiting --> Terminated | Trial primary completion date: Mar 2019 --> Sep 2018; funding unavailable
  • ||||||||||  Phase classification, Enrollment change:  LISA: Lifestyle Intervention Study in Adjuvant Treatment of Early Breast Cancer (clinicaltrials.gov) -  Sep 26, 2018   
    P=N/A,  N=338, Completed, 
    Trial completion date: Sep 2019 --> Sep 2018 | Active, not recruiting --> Terminated | Trial primary completion date: Mar 2019 --> Sep 2018; funding unavailable Phase classification: P3 --> P=N/A | N=2150 --> 338
  • ||||||||||  Premphase (conjugated estrogens/medroxyprogesterone acetate) / Pfizer
    Enrollment change, Trial termination:  Bioidentical 'Natural' Hormone Evaluation in Early Menopause (clinicaltrials.gov) -  Jun 3, 2018   
    P2,  N=21, Terminated, 
    Active, not recruiting --> Completed | Phase classification: P4 --> PN/A N=40 --> 21 | Completed --> Terminated
  • ||||||||||  Trial completion, Phase classification, Enrollment change:  Postmenopausal Women Estrogen and Progesterone Infusion (clinicaltrials.gov) -  Jun 3, 2018   
    P1/2,  N=20, Completed, 
    N=40 --> 21 | Completed --> Terminated Active, not recruiting --> Completed | Phase classification: PN/A --> P1/2 | N=40 --> 20
  • ||||||||||  risedronate / Generic mfg., alendronate / Generic mfg., ibandronate sodium hydrate / Generic mfg.
    Trial completion:  Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects (clinicaltrials.gov) -  Mar 6, 2018   
    P2,  N=410, Completed, 
    Active, not recruiting --> Completed | Phase classification: PN/A --> P1 | Trial completion date: Dec 2018 --> Jan 2018 Active, not recruiting --> Completed
  • ||||||||||  goserelin acetate / Generic mfg.
    Trial completion, Trial completion date, Metastases:  Study to Compare Zoladex (clinicaltrials.gov) -  Mar 1, 2018   
    P3,  N=222, Completed, 
    Phase classification: P4 --> P=N/A | N=60 --> 23 | Active, not recruiting --> Terminated; This study has been difficult to recruit. Active, not recruiting --> Completed | Trial completion date: Jan 2019 --> Nov 2017
  • ||||||||||  Trial completion, Trial completion date:  Transcranial Direct Current Stimulation (tDCS) in Vasomotor Symptoms of Menopause (clinicaltrials.gov) -  Mar 1, 2018   
    P=N/A,  N=30, Completed, 
    Active, not recruiting --> Completed | Trial completion date: Jan 2019 --> Nov 2017 Recruiting --> Completed | Trial completion date: May 2018 --> Aug 2017
  • ||||||||||  Aimovig (erenumab-aooe) / Amgen, Novartis
    Trial primary completion date:  Study of Erenumab (AMG 334) in Women With Hot Flashes (clinicaltrials.gov) -  Feb 27, 2018   
    P1,  N=103, Completed, 
    Recruiting --> Completed | Trial completion date: May 2018 --> Aug 2017 Trial primary completion date: Aug 2014 --> Mar 2014
  • ||||||||||  ethinyl estradiol/norgestimate / Generic mfg.
    Trial completion date, Trial primary completion date:  Oral Contraceptives, Insulin Resistance and Cardiovascular Risk Profile in Pre-Menopausal Women (clinicaltrials.gov) -  Feb 14, 2018   
    P4,  N=47, Active, not recruiting, 
    Trial primary completion date: Aug 2014 --> Mar 2014 Trial primary completion date: Dec 2017 --> Apr 2018 | Trial completion date: Dec 2017 --> Apr 2018
  • ||||||||||  NN1213 / Novo Nordisk
    Enrollment change, Trial termination:  Screening Evaluation for Women With Postpartum Depression (clinicaltrials.gov) -  Dec 27, 2017   
    P=N/A,  N=68, Terminated, 
    N=44 --> 25 | Trial primary completion date: Aug 2010 --> Dec 2010 N=650 --> 68 | Recruiting --> Terminated
  • ||||||||||  leuprolide acetate for depot suspension / Generic mfg.
    Trial completion, Phase classification, Enrollment change, Trial primary completion date:  Impact of Hot Flashes on Sleep and Mood Disturbance (clinicaltrials.gov) -  Dec 26, 2017   
    P4,  N=29, Completed, 
    N=650 --> 68 | Recruiting --> Terminated Active, not recruiting --> Completed | Phase classification: PN/A --> P4 | N=50 --> 29 | Trial primary completion date: Jun 2014 --> Dec 2011
  • ||||||||||  Trial completion:  Acupuncture for Obesity on Serum Metabolic Parameters (clinicaltrials.gov) -  Nov 17, 2017   
    P=N/A,  N=120, Completed, 
    Active, not recruiting --> Completed | Phase classification: PN/A --> P4 | N=50 --> 29 | Trial primary completion date: Jun 2014 --> Dec 2011 Recruiting --> Completed
  • ||||||||||  Enrollment change, Trial withdrawal, Trial primary completion date:  Bone Healing in Healthy and Post-menopausal Osteoporotic Women (clinicaltrials.gov) -  Oct 27, 2017   
    P=N/A,  N=0, Withdrawn, 
    N=42 --> 21 N=20 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Jun 2015 --> Dec 2014
  • ||||||||||  Phase classification, Adherence:  Adherence and Health Effects of Video Dance in Postmenopausal Women (clinicaltrials.gov) -  Oct 2, 2017   
    P=N/A,  N=168, Completed, 
    N=20 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Jun 2015 --> Dec 2014 Phase classification: P2 --> P=N/A
  • ||||||||||  Trial primary completion date:  Behavioral Treatment of Menopausal Insomnia; Sleep and Daytime Outcomes (clinicaltrials.gov) -  Aug 9, 2017   
    P=N/A,  N=150, Recruiting, 
    Recruiting --> Completed | Trial primary completion date: Sep 2015 --> Aug 2017 Trial primary completion date: Jan 2017 --> Jan 2018